Alejandro Dorenbaum

Corporate Officer/Principal at

Stanford University School of Medicine

66 year

Health Technology

Consumer Services

Profile

Dr. Alejandro Dorenbaum, MD, is a Chief Medical Officer at Reneo Pharmaceuticals, Inc. and a Clinical Professor-Pediatrics at Stanford University School of Medicine.
Dr. Dorenbaum was previously employed as a Chief Medical Officer by Allakos, Inc., a Chief Medical Officer by Lumena Pharmaceuticals, Inc., a Medical Director by Genentech, Inc., a Senior Director-Clinical Affairs by BioMarin Pharmaceutical, Inc., a Director-Clinical Development by Chiron Corp., and an Assistant Clinical Professor-Pediatrics by The University of California, San Francisco.
He received his doctorate degree from Universidad Nacional Autónoma de México.

Alejandro Dorenbaum active positions

Companies	Position	Start
Stanford University School of Medicine Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

All active positions of Alejandro Dorenbaum

Former positions of Alejandro Dorenbaum

Companies	Position	End
ALLAKOS INC.	Chief Tech/Sci/R&D Officer	2017-05-31
Lumena Pharmaceuticals, Inc. Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for rare liver diseases	Chief Tech/Sci/R&D Officer	2014-06-29
BIOMARIN PHARMACEUTICAL INC.	Chief Tech/Sci/R&D Officer	2008-12-31
Chiron Corp. Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening	Corporate Officer/Principal	2002-12-31
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	1999-12-31

See the detail of Alejandro Dorenbaum's experience

Training of Alejandro Dorenbaum

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alejandro Dorenbaum's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Chiron Corp. Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening	Health Technology
Genentech, Inc. Genentech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
BioMarin Pharmaceutical, Inc. BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions	Health Technology
Lumena Pharmaceuticals, Inc. Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for rare liver diseases	Health Technology
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Universidad Nacional Autónoma de México Universidad Nacional Autónoma de México Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Allakos, Inc. Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases	Health Technology
Stanford University School of Medicine Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Reneo Pharmaceuticals, Inc. Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases	Health Technology